Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kala Pharmaceuticals Inc

(NASDAQ: KALA)
Add to Portfolio
-0.02 (-0.30%)
as of 15:48 EST

Last 6.57
Change -0.02 (-0.30%)
Open 6.57
Prev. Close 6.59
Today's Range
6.38
6.63
52wk Range
3.24
9.25
Volume 227,720
Avg Volume 672,977
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
KALA -0.30% +65.25% -20.27%
DJIA -0.54% +4.24% +12.52%
S&P 500 -0.49% +7.14% +21.04%

Key Statistics

Annual EPS -2.76
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 241,070
Weighted Alpha -24.61
Standard Deviation +0.06
Profit Margin N/A
Beta 1.97

Growth Rates

YTD +79.13%
1-Year -26.53%

Opinion

Sell Hold Buy

Recent Headlines

Kala Pharmaceuticals Reports Inducement Grant Under

BusinessWire via COMTEX - 04:01PM EST
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted a non-statutory stock option to a new employee as an inducement award outside the Company's 2017 Equity Incentive Plan in accordance with NASDAQ Li(full story)
KALA: 6.57 (-0.02)

Kala Pharmaceuticals Reports Fourth Quarter and Full

BusinessWire via COMTEX - Wed Feb 12, 07:00AM EST
--- Achieved Full Year 2019 INVELTYS(R) Revenues of $6.1 Million -(full story)
KALA: 6.57 (-0.02)

Kala Pharmaceuticals to Report Fourth Quarter and Full

BusinessWire via COMTEX - Thu Feb 06, 08:00AM EST
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating particle (MPP) Drug Delivery Technology, t(full story)
KALA: 6.57 (-0.02)

Kala Pharmaceuticals Announces Completion of

BusinessWire via COMTEX - Wed Jan 15, 08:00AM EST
Kala Pharmaceuticals, Inc. (Kala) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating particle (MPP) Drug Delivery Techno(full story)
KALA: 6.57 (-0.02)

Kala Pharmaceuticals to Present at 38th Annual J.P.

BusinessWire via COMTEX - Wed Jan 08, 08:00AM EST
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY(TM) mucus-penetrating particle (MPP) Drug Delivery Technology, t(full story)
JPM: 137.25 (-0.24), KALA: 6.57 (-0.02)